Author response to Marrs et al., Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal

Br J Dermatol. 2015 Nov;173(5):1129-30. doi: 10.1111/bjd.14160.

Authors

K Anagnostou¹, A Clark²

Affiliations

¹ Department of Paediatric Allergy, Guy's and St Thomas' Hospitals NHS Foundation Trust, Westminster Bridge Road, London, U.K.
² Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Box 157, Cambridge, CB2 0QQ, U.K.

PMID: 26769643
DOI: 10.1111/bjd.14160

No abstract available

Publication types

Comment

MeSH terms

Desensitization, Immunologic / methods*
Female
Humans
Immunotherapy / methods*
Male
Peanut Hypersensitivity / immunology*
Peanut Hypersensitivity / prevention & control*